The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Phage Therapy Market Research Report 2024

Global Phage Therapy Market Research Report 2024

Publishing Date : Mar, 2024

License Type :
 

Report Code : 1707807

No of Pages : 107

Ask Your Query
Synopsis
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global Phage Therapy market was valued at US$ 32 million in 2023 and is anticipated to reach US$ 100.8 million by 2030, witnessing a CAGR of 17.6% during the forecast period 2024-2030.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
This report aims to provide a comprehensive presentation of the global market for Phage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phage Therapy.
Report Scope
The Phage Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Phage Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phage Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phage Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phage Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Phage Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Animal Health
1.3.3 Aquaculture
1.3.4 Agriculture
1.3.5 Food Industry
1.3.6 Human Health
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phage Therapy Market Perspective (2019-2030)
2.2 Phage Therapy Growth Trends by Region
2.2.1 Global Phage Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Phage Therapy Historic Market Size by Region (2019-2024)
2.2.3 Phage Therapy Forecasted Market Size by Region (2025-2030)
2.3 Phage Therapy Market Dynamics
2.3.1 Phage Therapy Industry Trends
2.3.2 Phage Therapy Market Drivers
2.3.3 Phage Therapy Market Challenges
2.3.4 Phage Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phage Therapy Players by Revenue
3.1.1 Global Top Phage Therapy Players by Revenue (2019-2024)
3.1.2 Global Phage Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phage Therapy Revenue
3.4 Global Phage Therapy Market Concentration Ratio
3.4.1 Global Phage Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phage Therapy Revenue in 2023
3.5 Phage Therapy Key Players Head office and Area Served
3.6 Key Players Phage Therapy Product Solution and Service
3.7 Date of Enter into Phage Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phage Therapy Breakdown Data by Type
4.1 Global Phage Therapy Historic Market Size by Type (2019-2024)
4.2 Global Phage Therapy Forecasted Market Size by Type (2025-2030)
5 Phage Therapy Breakdown Data by Application
5.1 Global Phage Therapy Historic Market Size by Application (2019-2024)
5.2 Global Phage Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Phage Therapy Market Size (2019-2030)
6.2 North America Phage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Phage Therapy Market Size by Country (2019-2024)
6.4 North America Phage Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phage Therapy Market Size (2019-2030)
7.2 Europe Phage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Phage Therapy Market Size by Country (2019-2024)
7.4 Europe Phage Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phage Therapy Market Size (2019-2030)
8.2 Asia-Pacific Phage Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Phage Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Phage Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Phage Therapy Market Size (2019-2030)
9.2 Latin America Phage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Phage Therapy Market Size by Country (2019-2024)
9.4 Latin America Phage Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phage Therapy Market Size (2019-2030)
10.2 Middle East & Africa Phage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Phage Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Phage Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NPO Microgen
11.1.1 NPO Microgen Company Detail
11.1.2 NPO Microgen Business Overview
11.1.3 NPO Microgen Phage Therapy Introduction
11.1.4 NPO Microgen Revenue in Phage Therapy Business (2019-2024)
11.1.5 NPO Microgen Recent Development
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Detail
11.2.2 Proteon Pharmaceuticals Business Overview
11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction
11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2019-2024)
11.2.5 Proteon Pharmaceuticals Recent Development
11.3 Phagelux
11.3.1 Phagelux Company Detail
11.3.2 Phagelux Business Overview
11.3.3 Phagelux Phage Therapy Introduction
11.3.4 Phagelux Revenue in Phage Therapy Business (2019-2024)
11.3.5 Phagelux Recent Development
11.4 Intralytix
11.4.1 Intralytix Company Detail
11.4.2 Intralytix Business Overview
11.4.3 Intralytix Phage Therapy Introduction
11.4.4 Intralytix Revenue in Phage Therapy Business (2019-2024)
11.4.5 Intralytix Recent Development
11.5 Micreos
11.5.1 Micreos Company Detail
11.5.2 Micreos Business Overview
11.5.3 Micreos Phage Therapy Introduction
11.5.4 Micreos Revenue in Phage Therapy Business (2019-2024)
11.5.5 Micreos Recent Development
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Detail
11.6.2 Eliava BioPreparations Business Overview
11.6.3 Eliava BioPreparations Phage Therapy Introduction
11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2019-2024)
11.6.5 Eliava BioPreparations Recent Development
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Detail
11.7.2 Locus Biosciences,Inc Business Overview
11.7.3 Locus Biosciences,Inc Phage Therapy Introduction
11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2019-2024)
11.7.5 Locus Biosciences,Inc Recent Development
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Detail
11.8.2 Pharmex Group,LLC Business Overview
11.8.3 Pharmex Group,LLC Phage Therapy Introduction
11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2019-2024)
11.8.5 Pharmex Group,LLC Recent Development
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Detail
11.9.2 Pherecydes Pharma Business Overview
11.9.3 Pherecydes Pharma Phage Therapy Introduction
11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2019-2024)
11.9.5 Pherecydes Pharma Recent Development
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Detail
11.10.2 APS Biocontrol Ltd. (APS) Business Overview
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction
11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2019-2024)
11.10.5 APS Biocontrol Ltd. (APS) Recent Development
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Detail
11.11.2 Qingdao Phagepharm Bio-tech Business Overview
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction
11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2019-2024)
11.11.5 Qingdao Phagepharm Bio-tech Recent Development
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Detail
11.12.2 Fixed-Phage Limited Business Overview
11.12.3 Fixed-Phage Limited Phage Therapy Introduction
11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2019-2024)
11.12.5 Fixed-Phage Limited Recent Development
11.13 Zeptometrix
11.13.1 Zeptometrix Company Detail
11.13.2 Zeptometrix Business Overview
11.13.3 Zeptometrix Phage Therapy Introduction
11.13.4 Zeptometrix Revenue in Phage Therapy Business (2019-2024)
11.13.5 Zeptometrix Recent Development
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Detail
11.14.2 Phage International, Inc. Business Overview
11.14.3 Phage International, Inc. Phage Therapy Introduction
11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2019-2024)
11.14.5 Phage International, Inc. Recent Development
11.15 MicroMir
11.15.1 MicroMir Company Detail
11.15.2 MicroMir Business Overview
11.15.3 MicroMir Phage Therapy Introduction
11.15.4 MicroMir Revenue in Phage Therapy Business (2019-2024)
11.15.5 MicroMir Recent Development
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Detail
11.16.2 iNtODEWORLD, Inc. Business Overview
11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction
11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2019-2024)
11.16.5 iNtODEWORLD, Inc. Recent Development
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Detail
11.17.2 NEXTBIOTICS Business Overview
11.17.3 NEXTBIOTICS Phage Therapy Introduction
11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2019-2024)
11.17.5 NEXTBIOTICS Recent Development
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Detail
11.18.2 Armata Pharmaceuticals, Inc. Business Overview
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction
11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2019-2024)
11.18.5 Armata Pharmaceuticals, Inc. Recent Development
11.19 Innophage
11.19.1 Innophage Company Detail
11.19.2 Innophage Business Overview
11.19.3 Innophage Phage Therapy Introduction
11.19.4 Innophage Revenue in Phage Therapy Business (2019-2024)
11.19.5 Innophage Recent Development
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Detail
11.20.2 Adaptive Phage Therapeutics Business Overview
11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction
11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2019-2024)
11.20.5 Adaptive Phage Therapeutics Recent Development
11.21 TechnoPhage
11.21.1 TechnoPhage Company Detail
11.21.2 TechnoPhage Business Overview
11.21.3 TechnoPhage Phage Therapy Introduction
11.21.4 TechnoPhage Revenue in Phage Therapy Business (2019-2024)
11.21.5 TechnoPhage Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Phage Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of DsDNA Bacteriophage
Table 3. Key Players of SsDNA Bacteriophage
Table 4. Key Players of SsRNA Bacteriophage
Table 5. Key Players of Others
Table 6. Global Phage Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Phage Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Phage Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Phage Therapy Market Share by Region (2019-2024)
Table 10. Global Phage Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Phage Therapy Market Share by Region (2025-2030)
Table 12. Phage Therapy Market Trends
Table 13. Phage Therapy Market Drivers
Table 14. Phage Therapy Market Challenges
Table 15. Phage Therapy Market Restraints
Table 16. Global Phage Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Phage Therapy Market Share by Players (2019-2024)
Table 18. Global Top Phage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2023)
Table 19. Ranking of Global Top Phage Therapy Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Phage Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Phage Therapy Product Solution and Service
Table 23. Date of Enter into Phage Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Phage Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Phage Therapy Revenue Market Share by Type (2019-2024)
Table 27. Global Phage Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Phage Therapy Revenue Market Share by Type (2025-2030)
Table 29. Global Phage Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Phage Therapy Revenue Market Share by Application (2019-2024)
Table 31. Global Phage Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Phage Therapy Revenue Market Share by Application (2025-2030)
Table 33. North America Phage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Phage Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Phage Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Phage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Phage Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Phage Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Phage Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Phage Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Phage Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Phage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Phage Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Phage Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Phage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Phage Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Phage Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 48. NPO Microgen Company Detail
Table 49. NPO Microgen Business Overview
Table 50. NPO Microgen Phage Therapy Product
Table 51. NPO Microgen Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 52. NPO Microgen Recent Development
Table 53. Proteon Pharmaceuticals Company Detail
Table 54. Proteon Pharmaceuticals Business Overview
Table 55. Proteon Pharmaceuticals Phage Therapy Product
Table 56. Proteon Pharmaceuticals Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 57. Proteon Pharmaceuticals Recent Development
Table 58. Phagelux Company Detail
Table 59. Phagelux Business Overview
Table 60. Phagelux Phage Therapy Product
Table 61. Phagelux Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 62. Phagelux Recent Development
Table 63. Intralytix Company Detail
Table 64. Intralytix Business Overview
Table 65. Intralytix Phage Therapy Product
Table 66. Intralytix Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 67. Intralytix Recent Development
Table 68. Micreos Company Detail
Table 69. Micreos Business Overview
Table 70. Micreos Phage Therapy Product
Table 71. Micreos Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 72. Micreos Recent Development
Table 73. Eliava BioPreparations Company Detail
Table 74. Eliava BioPreparations Business Overview
Table 75. Eliava BioPreparations Phage Therapy Product
Table 76. Eliava BioPreparations Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 77. Eliava BioPreparations Recent Development
Table 78. Locus Biosciences,Inc Company Detail
Table 79. Locus Biosciences,Inc Business Overview
Table 80. Locus Biosciences,Inc Phage Therapy Product
Table 81. Locus Biosciences,Inc Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 82. Locus Biosciences,Inc Recent Development
Table 83. Pharmex Group,LLC Company Detail
Table 84. Pharmex Group,LLC Business Overview
Table 85. Pharmex Group,LLC Phage Therapy Product
Table 86. Pharmex Group,LLC Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 87. Pharmex Group,LLC Recent Development
Table 88. Pherecydes Pharma Company Detail
Table 89. Pherecydes Pharma Business Overview
Table 90. Pherecydes Pharma Phage Therapy Product
Table 91. Pherecydes Pharma Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 92. Pherecydes Pharma Recent Development
Table 93. APS Biocontrol Ltd. (APS) Company Detail
Table 94. APS Biocontrol Ltd. (APS) Business Overview
Table 95. APS Biocontrol Ltd. (APS) Phage Therapy Product
Table 96. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 97. APS Biocontrol Ltd. (APS) Recent Development
Table 98. Qingdao Phagepharm Bio-tech Company Detail
Table 99. Qingdao Phagepharm Bio-tech Business Overview
Table 100. Qingdao Phagepharm Bio-tech Phage Therapy Product
Table 101. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 102. Qingdao Phagepharm Bio-tech Recent Development
Table 103. Fixed-Phage Limited Company Detail
Table 104. Fixed-Phage Limited Business Overview
Table 105. Fixed-Phage Limited Phage Therapy Product
Table 106. Fixed-Phage Limited Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 107. Fixed-Phage Limited Recent Development
Table 108. Zeptometrix Company Detail
Table 109. Zeptometrix Business Overview
Table 110. Zeptometrix Phage Therapy Product
Table 111. Zeptometrix Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 112. Zeptometrix Recent Development
Table 113. Phage International, Inc. Company Detail
Table 114. Phage International, Inc. Business Overview
Table 115. Phage International, Inc. Phage Therapy Product
Table 116. Phage International, Inc. Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 117. Phage International, Inc. Recent Development
Table 118. MicroMir Company Detail
Table 119. MicroMir Business Overview
Table 120. MicroMir Phage Therapy Product
Table 121. MicroMir Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 122. MicroMir Recent Development
Table 123. iNtODEWORLD, Inc. Company Detail
Table 124. iNtODEWORLD, Inc. Business Overview
Table 125. iNtODEWORLD, Inc. Phage Therapy Product
Table 126. iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 127. iNtODEWORLD, Inc. Recent Development
Table 128. NEXTBIOTICS Company Detail
Table 129. NEXTBIOTICS Business Overview
Table 130. NEXTBIOTICS Phage Therapy Product
Table 131. NEXTBIOTICS Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 132. NEXTBIOTICS Recent Development
Table 133. Armata Pharmaceuticals, Inc. Company Detail
Table 134. Armata Pharmaceuticals, Inc. Business Overview
Table 135. Armata Pharmaceuticals, Inc. Phage Therapy Product
Table 136. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 137. Armata Pharmaceuticals, Inc. Recent Development
Table 138. Innophage Company Detail
Table 139. Innophage Business Overview
Table 140. Innophage Phage Therapy Product
Table 141. Innophage Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 142. Innophage Recent Development
Table 143. Adaptive Phage Therapeutics Company Detail
Table 144. Adaptive Phage Therapeutics Business Overview
Table 145. Adaptive Phage Therapeutics Phage Therapy Product
Table 146. Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 147. Adaptive Phage Therapeutics Recent Development
Table 148. TechnoPhage Company Detail
Table 149. TechnoPhage Business Overview
Table 150. TechnoPhage Phage Therapy Product
Table 151. TechnoPhage Revenue in Phage Therapy Business (2019-2024) & (US$ Million)
Table 152. TechnoPhage Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phage Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Phage Therapy Market Share by Type: 2023 VS 2030
Figure 3. DsDNA Bacteriophage Features
Figure 4. SsDNA Bacteriophage Features
Figure 5. SsRNA Bacteriophage Features
Figure 6. Others Features
Figure 7. Global Phage Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Phage Therapy Market Share by Application: 2023 VS 2030
Figure 9. Animal Health Case Studies
Figure 10. Aquaculture Case Studies
Figure 11. Agriculture Case Studies
Figure 12. Food Industry Case Studies
Figure 13. Human Health Case Studies
Figure 14. Others Case Studies
Figure 15. Phage Therapy Report Years Considered
Figure 16. Global Phage Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Phage Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Phage Therapy Market Share by Region: 2023 VS 2030
Figure 19. Global Phage Therapy Market Share by Players in 2023
Figure 20. Global Top Phage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Phage Therapy Revenue in 2023
Figure 22. North America Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Phage Therapy Market Share by Country (2019-2030)
Figure 24. United States Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Phage Therapy Market Share by Country (2019-2030)
Figure 28. Germany Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Phage Therapy Market Share by Region (2019-2030)
Figure 36. China Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Phage Therapy Market Share by Country (2019-2030)
Figure 44. Mexico Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Phage Therapy Market Share by Country (2019-2030)
Figure 48. Turkey Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. NPO Microgen Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 51. Proteon Pharmaceuticals Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 52. Phagelux Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 53. Intralytix Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 54. Micreos Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 55. Eliava BioPreparations Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 56. Locus Biosciences,Inc Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 57. Pharmex Group,LLC Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 58. Pherecydes Pharma Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 59. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 60. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 61. Fixed-Phage Limited Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 62. Zeptometrix Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 63. Phage International, Inc. Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 64. MicroMir Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 65. iNtODEWORLD, Inc. Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 66. NEXTBIOTICS Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 67. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 68. Innophage Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 69. Adaptive Phage Therapeutics Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 70. TechnoPhage Revenue Growth Rate in Phage Therapy Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock